You just read:

MabVax Therapeutics Reports on Interim Progress on Its Programs Including the Phase I Clinical Trial for Therapeutic Antibody Treatment of Pancreatic Cancer

News provided by

MabVax Therapeutics Holdings, Inc.

Sep 19, 2016, 09:05 ET